Preprint
Article

This version is not peer-reviewed.

Menopausal Symptoms, Mental Health and Psychosocial Functioning Among Postmenopausal Healthcare Workers: A Cross-Sectional Study

Submitted:

16 November 2026

Posted:

18 November 2026

You are already at the latest version

Abstract
Objectives: To examine associations of menopausal symptoms, reproductive history, and socioeconomic and occupational factors with depressive symptoms, anxiety symptoms and psychosocial functioning among postmenopausal healthcare workers. Methods: A single-centre cross-sectional study included 162 postmenopausal healthcare workers at a public general hospital in Greece. Data covered reproductive and menopausal characteristics, sociodemographic and occupational factors, mental health history and lifestyle. Outcomes were assessed using the Beck Depression Inventory (BDI), Hamilton Anxiety Rating Scale (HAM-A) and Brief Inventory of Psychosocial Functioning (BIPF). Analyses included non-parametric tests, Spearman correlations and hierarchical linear regression. Results: Participants’ mean age was 55.35 years. The most frequently reported menopausal symptoms were mood changes (62.3%), reduced sexual desire (61.7%) and sleep changes (59.9%). In multivariable analyses, greater financial difficulty, previous mental health diagnosis, family history of mental illness and self-reported weight gain or fat redistribution were associated with higher BDI scores. Older age was associated with lower HAM-A scores (B = −0.495; 95% CI −0.823 to −0.167). Greater financial difficulty and holding a position of professional responsibility were associated with greater psychosocial impairment. Conclusions: Psychological symptoms and psychosocial impairment among postmenopausal healthcare workers were associated with socioeconomic circumstances, mental health history, perceived weight changes and professional responsibility. Assessment of women’s health needs after menopause should consider these concerns alongside menopausal symptoms. The cross-sectional design precludes conclusions about causality.
Keywords: 
;  ;  ;  ;  ;  ;  

1. Introduction

Menopause marks the permanent cessation of menstruation following the loss of ovarian follicular activity [1]. Although it is defined by a reproductive event, the symptoms accompanying this stage of life can extend to sleep, sexual health, psychological well-being and daily functioning. Vasomotor symptoms, vaginal dryness or discomfort, and changes in body weight or fat distribution are common concerns, but women differ considerably in the symptoms they experience and how these affect their lives [2,3,4,6,7,8].
The menopausal transition and postmenopause are distinct stages. The transition encompasses changes in menstrual patterns leading up to the final menstrual period, whereas natural menopause is established retrospectively after 12 consecutive months of amenorrhoea without another evident cause [1]. Much of the research on psychological symptoms concerns the transition, but sleep difficulties, sexual concerns and other symptoms may remain relevant after menopause [2,6,8]. Findings from women undergoing the transition therefore need to be interpreted carefully when considering postmenopausal populations.
Depressive and anxiety symptoms are reported during this period, although their occurrence cannot be attributed to reproductive ageing alone [3,5]. Reproductive history, age at menopause and the mode of menopause may contribute to differences in women’s experiences [9]. Bilateral oophorectomy causes an abrupt loss of ovarian hormone production, and previous studies have associated premenopausal bilateral oophorectomy with subsequent depressive and anxiety symptoms [10,11]. Mental health history and socioeconomic circumstances also warrant consideration when examining psychological symptoms after menopause.
Psychological symptom severity and psychosocial functioning describe related but different aspects of health. Measures of depression and anxiety assess symptom burden, while psychosocial functioning concerns women’s ability to participate in relationships, work, parenting and self-care [12]. Assessing both allows a broader examination of health needs: symptom scores alone do not describe the difficulties a woman may experience in her everyday activities. This distinction is particularly relevant when studying women who combine professional duties with responsibilities outside work.
Healthcare workers face shift schedules, time pressure and the emotional demands of patient care. These conditions may make menopausal symptoms more difficult to manage, particularly when sleep or concentration is affected. Previous studies among nurses and other working women have reported associations between menopausal symptoms, work impairment, lower job satisfaction and burnout [4,13,14,15]. Healthcare workers therefore provide a relevant population in which to examine menopausal symptoms alongside occupational and personal circumstances.
Examining these factors together may help distinguish associations that persist after adjustment from those that overlap with age, mental health history or socioeconomic circumstances. Evidence remains limited on reproductive, menopausal, socioeconomic and occupational factors considered jointly in relation to both psychological symptoms and psychosocial functioning among postmenopausal healthcare workers. This study examined their associations with depressive symptoms, anxiety symptoms and psychosocial functioning among healthcare workers at a public general hospital in Greece.

2. Materials and Methods

2.1. Study Design and Setting

A single-centre cross-sectional study was conducted among postmenopausal healthcare workers employed at a public general hospital in Greece. Data were collected between 20 March and 20 June 2026. Reproductive and menopausal characteristics, sociodemographic and occupational factors, mental health history, lifestyle and psychometric outcomes were assessed at a single time point.

2.2. Eligibility Criteria

Healthcare workers were eligible if they were postmenopausal and able to provide informed consent. Natural menopause was defined as at least 12 consecutive months of amenorrhoea without another evident cause. Surgical menopause was defined as the loss of ovarian function following bilateral oophorectomy. Women who had not reached menopause, declined participation or provided insufficient data for the primary outcomes were excluded.

2.3. Study Size and Recruitment Strategy

Approximately 250 female healthcare workers were aged 50 years or older. Recruitment aimed to include all eligible postmenopausal healthcare workers during the study period. No formal a priori sample-size calculation was performed. The final analytical sample comprised 162 women who met the eligibility criteria and provided informed consent.

2.4. Data Collection

Before participation, women received written information about the study aims, voluntary participation, confidentiality and the reporting of aggregated results. Informed consent was obtained before data collection.
Participants completed the questionnaire individually, either electronically or on paper, with the researcher present. Sociodemographic, occupational, reproductive, menopausal, mental health and lifestyle information was self-reported. The BDI and B-IPF were completed independently by participants, while the HAM-A was administered and rated by the researcher. No direct personal identifiers were collected in the study questionnaire.

2.5. Ethical Considerations

The study was approved by the Scientific Committee of the participating hospital (No. 53518; 3 November 2025) and the Research Ethics and Deontology Committee of the authors’ university (No. 357; 10 February 2026). It was conducted in accordance with the Declaration of Helsinki. Participation was voluntary, and all participants provided informed consent before data collection.

2.6. Variables and Measures

Data were collected using a structured questionnaire and three psychometric measures. The questionnaire recorded age, education, marital and financial status, profession, duration of employment, professional responsibility and work schedule. It also covered reproductive history, menopausal timing and mode, menopausal symptoms and treatments, previous mental health diagnosis, family history of mental illness, smoking, alcohol consumption and physical activity.
Depressive symptoms were assessed using the 21-item Beck Depression Inventory (BDI), a self-report measure with total scores ranging from 0 to 63. Higher scores indicate greater depressive symptom severity [16]. A Greek-language version supported by previous standardization and psychometric studies was used [17,18].
Anxiety symptoms were assessed using the Hamilton Anxiety Rating Scale (HAM-A), a 14-item clinician-rated measure of psychological and somatic anxiety [19]. Each item is scored from 0 to 4, giving a total score of 0–56, with higher scores indicating greater anxiety symptom severity. The researcher administered and rated the scale based on participants’ reported symptoms and, for the final item, behavioural observations. A Greek-language version following the structure of the original scale was used [20].
Psychosocial functioning was assessed using the seven-item Brief Inventory of Psychosocial Functioning (B-IPF). The instrument assesses difficulties during the preceding 30 days across domains that include relationships, parenting, work, education and self-care [12]. The Greek version was used [21], with higher scores indicating greater psychosocial impairment.

2.7. Statistical Analysis

Analyses were performed using IBM SPSS Statistics, version 26. Continuous variables were summarized as means and standard deviations (SD), and medians and ranges. Categorical variables were presented as frequencies and percentages.
Because the psychometric scores were not normally distributed, group comparisons used the Mann–Whitney U test or the Kruskal–Wallis test, as appropriate. Spearman’s rank correlation coefficient was used to examine associations between continuous or ordinal variables. Internal consistency of the psychometric measures was assessed using Cronbach’s alpha.
Separate hierarchical linear regression models were fitted for BDI, HAM-A and B-IPF scores. Variables were selected based on univariable findings and their theoretical or clinical relevance. Results were reported as unstandardized coefficients (B), standard errors (SE), standardized coefficients (β), 95% confidence intervals (CI) and p-values. Multicollinearity was assessed using tolerance and variance inflation factor (VIF) values. All tests were two-sided, with statistical significance set at p < 0.05.

3. Results

3.1. Participant Characteristics

The analytical sample comprised 162 postmenopausal healthcare workers, all of whom completed the primary outcome measures. Their mean age was 55.35 years (SD 4.25). Most participants were married (71.6%), 48.1% had postgraduate education and 38.3% were midwives. Almost half (44.4%) had worked in healthcare for more than 20 years. Positions of professional responsibility were held by 22.2%, while 49.4% worked rotating schedules. Detailed sociodemographic and occupational characteristics are presented in Supplementary Table S1.

3.2. Reproductive and Menopausal Characteristics

The mean age at the final menstrual period was 48.96 years (SD 4.31). Natural menopause was reported by 87.7% of participants, and surgical menopause following bilateral oophorectomy by 12.3%. The most frequently reported menopausal symptoms were mood changes (62.3%), reduced sexual desire (61.7%), sleep changes (59.9%), vaginal dryness or discomfort (58.0%), and weight gain or fat redistribution (57.4%). Reproductive and menopausal characteristics are presented in Table 1.

3.3. Mental Health History and Lifestyle Characteristics

A previous mental health diagnosis was reported by 11.1% of participants, and 5.6% reported a family history of mental illness. Approximately one-third (34.6%) reported no regular physical activity. Further details on mental health history and lifestyle characteristics are presented in Supplementary Table S2.

3.4. Psychometric Outcomes

Internal consistency was high for all three measures, with Cronbach’s alpha values of 0.941 for the BDI, 0.933 for the HAM-A and 0.895 for the B-IPF.
The mean BDI score was 12.16 (SD 11.52; median 9.00; range 0–52), and the mean HAM-A score was 15.80 (SD 10.46; median 14.50; range 0–49). The mean B-IPF score was 24.56 (SD 25.21; median 16.67; range 0–116.67). Higher scores indicate greater depressive symptoms, anxiety symptoms and psychosocial impairment, respectively.

3.5. Univariable Associations with Psychometric Outcomes

In univariable analyses, vasomotor symptoms, sleep changes, genitourinary symptoms and weight gain or fat redistribution were associated with scores on one or more of the three psychometric measures. Associations were also observed for socioeconomic characteristics and personal or family mental health history. Detailed comparisons for BDI, HAM-A and B-IPF scores are presented in Supplementary Table S3–S5, respectively.

3.6. Correlations Between Psychometric Outcomes and Age-Related Reproductive Variables

The three psychometric scores were positively correlated. BDI scores correlated with HAM-A scores (ρ = 0.586, p < 0.001) and B-IPF scores (ρ = 0.500, p < 0.001). HAM-A scores also correlated with B-IPF scores (ρ = 0.567, p < 0.001).
HAM-A scores were negatively correlated with current age (ρ = −0.286, p < 0.05) and age at the final menstrual period (ρ = −0.206, p < 0.05), and positively correlated with age at menarche (ρ = 0.187, p < 0.05). None of these age variables showed statistically significant correlations with BDI or B-IPF scores. The complete correlation matrix is presented in Supplementary Table S6.

3.7. Multivariable Regression Analyses

In the final BDI model, greater financial difficulty was associated with higher depressive symptom scores (B = 2.083, 95% CI 0.552–3.615; p = 0.008). Higher scores were also associated with a previous mental health diagnosis (B = −2.892, 95% CI −4.993 to −0.790; p = 0.007), a family history of mental illness (B = −12.135, 95% CI −18.791 to −5.479; p < 0.001), and self-reported weight gain or fat redistribution (B = −3.677, 95% CI −7.023 to −0.330; p = 0.032). These three variables were coded as 1 = Yes and 2 = No; their negative coefficients therefore indicate lower BDI scores in the No category relative to the Yes category (Table 2).
In the final HAM-A model, age was the only variable that remained statistically significant. Each additional year of age was associated with a 0.495-point lower HAM-A score (B = −0.495, 95% CI −0.823 to −0.167; p = 0.003) (Table 3).
In the final B-IPF model, greater financial difficulty was associated with greater psychosocial impairment (B = 4.242, 95% CI 0.358–8.126; p = 0.033). Holding a position of professional responsibility was associated with a 14.718-point higher B-IPF score (B = 14.718, 95% CI 5.198–24.238; p = 0.003) (Table 4).

4. Discussion

This study examined factors associated with depressive symptoms, anxiety symptoms and psychosocial functioning among postmenopausal healthcare workers. In the adjusted analyses, financial difficulty, personal and family mental health history, and self-reported weight gain or fat redistribution were associated with higher depressive symptom scores. Younger age was associated with greater anxiety symptom severity, while financial difficulty and professional responsibility were associated with greater psychosocial impairment. These findings suggest that assessments of health after menopause should consider women’s socioeconomic and occupational circumstances alongside menopausal symptoms and mental health history.
Hot flashes and night sweats were associated with higher depressive and anxiety symptom scores and greater psychosocial impairment in the univariable analyses. These findings are consistent with previous research linking vasomotor symptoms to sleep difficulties, emotional well-being, daily functioning and work ability [2,3,4]. For healthcare workers, such symptoms may be difficult to manage alongside duties requiring sustained attention and frequent interaction with patients and colleagues. The associations did not remain statistically significant in the adjusted models. This limits the evidence for an association independent of the other variables included in these models, but does not establish that vasomotor symptoms are unrelated to psychological or functional difficulties.
Self-reported sleep changes were associated with higher depressive and anxiety symptom scores and greater psychosocial impairment in the univariable analyses. Previous research has linked sleep disturbance during the menopausal transition to fatigue, irritability, difficulties in daily functioning and affective symptoms [6,8]. Findings from the InterLACE consortium also suggest that sleep difficulties may partly mediate the association between vasomotor symptoms and depressed mood [7]. In the present study, sleep changes did not remain statistically significant in the adjusted models. Although this may reflect overlap with other measured factors, the cross-sectional data cannot establish the temporal relationships between sleep changes, menopausal symptoms and psychological distress.
Women reporting surgical menopause following bilateral oophorectomy had higher anxiety symptom scores in the univariable analysis. Bilateral oophorectomy causes an abrupt loss of ovarian hormone production, and previous studies have reported increased depressive and anxiety symptoms following premenopausal risk-reducing bilateral salpingo-oophorectomy or early bilateral oophorectomy [10,11]. These findings provide relevant context, although the populations and timing of surgery may differ from those in the present study. Mode of menopause did not remain statistically significant in the adjusted HAM-A model. The unadjusted association should therefore be interpreted cautiously, particularly given the small proportion of participants with surgical menopause (12.3%).
Self-reported weight gain or fat redistribution was the only menopausal symptom that remained statistically significant in the adjusted BDI model. Participants reporting these changes had higher depressive symptom scores after adjustment for the other variables included in the model. This finding concerns self-reported bodily changes and does not establish their timing or direction of association with depressive symptoms. Further research incorporating repeated assessments and objective measures of weight and body composition would help clarify this relationship.
Age was the only variable that remained statistically significant in the adjusted HAM-A model, with younger participants having higher anxiety symptom scores. Current age should not be equated with age at menopause: this finding does not establish that women who experienced menopause earlier had greater anxiety. Nor does it demonstrate that anxiety decreases as individual women grow older, because participants were assessed at a single time point. Longitudinal research could clarify how anxiety symptoms change after menopause and whether these patterns differ according to age at menopause, time since menopause and occupational circumstances.
Greater financial difficulty and holding a position of professional responsibility were associated with greater psychosocial impairment in the adjusted model. Financial difficulty was also associated with depressive symptoms, making it relevant to more than one outcome in this sample. The association with professional responsibility raises questions about the demands accompanying these roles, although workload, perceived stress and organizational support were not directly assessed.
Previous studies have emphasized the relevance of working conditions and managerial support to women’s experiences of menopause at work [13,14,15]. Asiamah et al. also reported relationships between menopausal symptoms, depression, anxiety, sleep quality and job satisfaction among middle-aged healthcare workers [22]. These studies provide occupational context, but job satisfaction and psychosocial functioning are distinct outcomes. The present findings suggest that financial circumstances and professional responsibilities deserve consideration when assessing daily functioning among postmenopausal healthcare workers.
The findings support considering mental health and daily functioning alongside physical symptoms when assessing women’s health after menopause. For healthcare workers, this assessment could also explore financial difficulties and professional responsibilities, with referral for further evaluation or support where appropriate. Menopausal symptoms should not automatically be assumed to explain psychological distress, particularly when a woman reports a previous mental health diagnosis.
At the workplace level, previous research supports attention to managerial awareness, working conditions and opportunities to discuss menopausal concerns without stigma [13,14,15,22]. These approaches are relevant to healthcare settings, although the present study did not evaluate workplace interventions or their effectiveness. Its contribution is to identify factors associated with psychological symptoms and psychosocial impairment that may inform further assessment and research.

4.1. Strengths and Limitations

A strength of this study is the assessment of depressive symptoms, anxiety symptoms and psychosocial functioning within the same sample of postmenopausal healthcare workers. Examining these distinct but related outcomes provided a broader picture than symptom assessment alone. The inclusion of reproductive, menopausal, socioeconomic and occupational characteristics allowed their associations to be examined together. All 162 participants completed the primary outcome measures, and the three psychometric instruments showed high internal consistency in this sample.
Several limitations should also be considered. The cross-sectional design prevents conclusions about causality or the temporal order of the observed associations. Recruitment from a single public hospital limits generalizability to other healthcare settings and to postmenopausal women outside the healthcare workforce. Voluntary participation may have introduced selection bias.
Reproductive history, menopausal symptoms and mental health history were self-reported and may be subject to recall or reporting bias. Reported weight gain or fat redistribution was not an objective measure of change in body weight or composition. The psychometric scores assessed symptoms and functioning and should not be interpreted as clinical diagnoses.
Relatively few participants reported surgical menopause or a family history of mental illness, limiting the precision of estimates involving these groups. The number of univariable comparisons also warrants caution because of the possibility of chance findings. Finally, adjustment was limited to the variables included in the regression models, and residual confounding cannot be excluded.

5. Conclusions

Among postmenopausal healthcare workers at a public hospital in Greece, depressive symptoms were associated with financial difficulty, personal and family mental health history, and self-reported weight gain or fat redistribution. Younger age was associated with greater anxiety symptom severity, while financial difficulty and professional responsibility were associated with greater psychosocial impairment. These findings support considering psychological symptoms, daily functioning and socioeconomic circumstances alongside menopausal concerns when assessing women’s health after menopause. Longitudinal studies in larger, multicentre samples are needed to clarify the temporal relationships and assess whether these findings extend to other settings.

Supplementary Materials

The following supporting information can be downloaded at the website of this paper posted on Preprints.org.

Author Contributions

Conceptualization, D.V. and E.O.; methodology, E.O., D.P. and A.S.; formal analysis, E.O.; investigation, D.V.; data curation, D.V.; writing—original draft preparation, D.V.; writing—review and editing, E.O., D.P. and A.S.; supervision, E.O., D.P. and A.S.; project administration, E.O. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Special Account for Research Funds (ELKE) of the University of Western Macedonia.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Scientific Committee of the General Hospital of Kozani “Mamatsio” (approval No. 53518; 3 November 2025) and the Research Ethics and Deontology Committee of the University of Western Macedonia (approval No. 357; 10 February 2026).

Data Availability Statement

The data supporting the findings of this study are not publicly available due to participant privacy and confidentiality considerations. Requests for access may be directed to the corresponding author and will be considered subject to applicable ethical and data protection requirements.

Conflicts of Interest

The authors declare no conflicts of interest. The funder had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Harlow, S.D.; Gass, M.; Hall, J.E.; Lobo, R.; Maki, P.; Rebar, R.W.; Sherman, S.; Sluss, P.M.; de Villiers, T.J. STRAW + 10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop + 10: Addressing the unfinished agenda of staging reproductive aging. J. Clin. Endocrinol. Metab. 2012, 97, 1159–1168. [Google Scholar] [CrossRef] [PubMed]
  2. The 2022 Hormone Therapy Position Statement of The North American Menopause Society Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause 2022, 29, 767–794. [CrossRef] [PubMed]
  3. Brown, L.; Hunter, M.S.; Chen, R.; Crandall, C.J.; Gordon, J.L.; Mishra, G.D.; Rother, V.; Joffe, H.; Hickey, M. Promoting good mental health over the menopause transition. Lancet 2024, 403, 969–983. [Google Scholar] [CrossRef] [PubMed]
  4. DePree, B.; Shiozawa, A.; King, D.; Schild, A.; Zhou, M.; Yang, H.; Mancuso, S. Association of menopausal vasomotor symptom severity with sleep and work impairments: A US survey. Menopause 2023, 30, 887–897. [Google Scholar] [CrossRef] [PubMed]
  5. Freeman, E.W. Depression in the menopause transition: Risks in the changing hormone milieu as observed in the general population. Womens Midlife Health 2015, 1, 2. [Google Scholar] [CrossRef] [PubMed]
  6. Baker, F.C.; de Zambotti, M.; Colrain, I.M.; Bei, B. Sleep problems during the menopausal transition: Prevalence, impact, and management challenges. Nat. Sci. Sleep 2018, 10, 73–95. [Google Scholar] [CrossRef] [PubMed]
  7. Chung, H.F.; Pandeya, N.; Dobson, A.J.; Kuh, D.; Brunner, E.J.; Crawford, S.L.; Avis, N.E.; Gold, E.B.; Mitchell, E.S.; Woods, N.F.; Bromberger, J.T.; Thurston, R.C.; Joffe, H.; Yoshizawa, T.; Anderson, D.; Mishra, G.D. The role of sleep difficulties in the vasomotor menopausal symptoms and depressed mood relationships: An international pooled analysis of eight studies in the InterLACE consortium. Psychol. Med. 2018, 48, 2550–2561. [Google Scholar] [CrossRef] [PubMed]
  8. Maki, P.M.; Panay, N.; Simon, J.A. Sleep disturbance associated with the menopause. Menopause 2024, 31, 724–733. [Google Scholar] [CrossRef] [PubMed]
  9. Sharami, S.H.; Faraji Darkhaneh, R.; Ghanami Gashti, N.; Mansour-Ghanaei, M.; Bab Eghbal, S. The association between reproductive history and menopausal symptoms: An evidence from the cross-sectional survey. BMC Womens Health 2022, 22, 136. [Google Scholar] [CrossRef] [PubMed]
  10. Hickey, M.; Moss, K.M.; Brand, A.; Wrede, C.D.; Domchek, S.M.; Meiser, B.; Mishra, G.D.; Joffe, H. What happens after menopause? (WHAM): A prospective controlled study of depression and anxiety up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy. Gynecol. Oncol. 2021, 161, 527–534. [Google Scholar] [CrossRef] [PubMed]
  11. Rocca, W.A.; Grossardt, B.R.; Geda, Y.E.; Gostout, B.S.; Bower, J.H.; Maraganore, D.M.; de Andrade, M.; Melton, L.J., III. Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy. Menopause 2008, 15, 1050–1059. [Google Scholar] [CrossRef] [PubMed]
  12. Bovin, M.J.; Black, S.K.; Rodriguez, P.; Lunney, C.A.; Kleiman, S.E.; Weathers, F.W.; Schnurr, P.P.; Spira, J.; Keane, T.M.; Marx, B.P. Development and validation of a measure of PTSD-related psychosocial functional impairment: The Inventory of Psychosocial Functioning. Psychol. Serv. 2018, 15, 216–229. [Google Scholar] [CrossRef] [PubMed]
  13. Converso, D.; Viotti, S.; Sottimano, I.; Loera, B.; Molinengo, G.; Guidetti, G. The relationship between menopausal symptoms and burnout. A cross-sectional study among nurses. BMC Womens Health 2019, 19, 148. [Google Scholar] [CrossRef] [PubMed]
  14. Hardy, C.; Thorne, E.; Griffiths, A.; Hunter, M.S. Work outcomes in midlife women: The impact of menopause, work stress and working environment. Womens Midlife Health 2018, 4, 3. [Google Scholar] [CrossRef] [PubMed]
  15. Hardy, C.; Griffiths, A.; Hunter, M.S. What do working menopausal women want? A qualitative investigation into women’s perspectives on employer and line manager support. Maturitas 2017, 101, 37–41. [Google Scholar] [CrossRef] [PubMed]
  16. Beck, A.T.; Ward, C.H.; Mendelson, M.; Mock, J.; Erbaugh, J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4, 561–571. [Google Scholar] [CrossRef] [PubMed]
  17. Tzemos, I. The Standardization of the Beck Depression Inventory in a Greek Population Sample. Doctoral Dissertation, National and Kapodistrian University of Athens, Athens, Greece, 1984. [Google Scholar] [CrossRef]
  18. Fountoulakis, K.N.; Iacovides, A.; Kleanthous, S.; Samolis, S.; Gougoulias, K.; St Kaprinis, G.; Bech, P. The Greek translation of the symptoms rating scale for depression and anxiety: Preliminary results of the validation study. BMC Psychiatry 2003, 3, 21. [Google Scholar] [CrossRef] [PubMed]
  19. Hamilton, M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 1959, 32, 50–55. [Google Scholar] [CrossRef] [PubMed]
  20. Skalidou, S.; Anestis, A.; Skalidis, E.; Kontaxi, O.; Kyrezi, A.; Konstantinou, P.; Papadimitriou, K. A repeated cross-sectional pilot study of physical activity, levels of depression and anxiety during the COVID-19 pandemic in young Greek adults. Healthcare 2023, 11, 2493. [Google Scholar] [CrossRef] [PubMed]
  21. Rigas, N.; Sarantaki, A.; Dagla, M.; Gourounti, K.; Tzitiridou Chatzopoulou, M.; Kyritsis, Z.; Antoniou, E.; Orovou, E. Psychometric validation of the Greek version of the Brief Inventory Psychosocial Functioning Scale in healthcare paediatric professionals. Discov. Psychol. 2026, 6, 66. [Google Scholar] [CrossRef]
  22. Asiamah, N.; Cronin, C.; Abbott, J.E.; Smith, S. Interactions of depression, anxiety, and sleep quality with menopausal symptoms on job satisfaction among middle-aged health workers in England: A STROBE-based analysis. Hum. Resour. Health 2024, 22, 64. [Google Scholar] [CrossRef] [PubMed]
Table 1. Reproductive and menopausal characteristics of the study sample.
Table 1. Reproductive and menopausal characteristics of the study sample.
Variable n or value %
Age at menarche, years 13.07 (2.98); 13.00 (10–17)
Number of pregnancies
0 16 9.9
1 22 13.6
2 69 42.6
3 41 25.3
4 9 5.6
5 5 3.1
Number of miscarriages/pregnancy terminations
0 122 75.3
1 22 13.6
2 11 6.8
3 5 3.1
4 1 0.6
7 1 0.6
Type of delivery
No delivery reported 18 11.1
Vaginal delivery 101 62.3
Vaginal delivery with interventions 31 19.1
Cesarean section 12 7.4
Breastfeeding
Yes 104 64.2
No 58 35.8
Age at final menstrual period, years 48.96 (4.31); 50.00 (30–56)
Mode of menopause
Natural/spontaneous 142 87.7
Surgical menopause following bilateral oophorectomy 20 12.3
Irregular menstrual cycles before the final menstrual period
Yes 83 51.2
No 79 48.8
Cycle disturbances >1 year before final menstrual period
Yes 73 45.1
No 89 54.9
Postmenopausal bleeding after ≥12 months of amenorrhoea
Yes 44 27.2
No 118 72.8
Hot flashes
None 40 24.7
Mild 51 31.5
Moderate 52 32.1
Severe 19 11.7
Night sweats
None 52 32.1
Mild 51 31.5
Moderate 44 27.2
Severe 15 9.3
Sleep changes
Yes 97 59.9
No 65 40.1
Mood changes
Yes 101 62.3
No 61 37.7
Reduced sexual desire
Yes 100 61.7
No 62 38.3
Vaginal dryness or discomfort
Yes 94 58.0
No 68 42.0
Weight gain or fat redistribution
Yes 93 57.4
No 69 42.6
Menopausal hormone therapy
Yes 19 11.7
No 143 88.3
Herbal or alternative preparations for menopausal symptoms
Yes 15 9.3
No 147 90.7
Notes: Values are presented as n (%) unless otherwise indicated. For continuous variables, values are presented as mean (SD); median (range). SD, standard deviation.
Table 2. Final hierarchical linear regression model for BDI total score.
Table 2. Final hierarchical linear regression model for BDI total score.
Variable B SE β 95% CI for B p-value VIF
Age -0.229 0.158 -0.100 -0.541 to 0.082 0.147 1.122
Financial status 2.083 0.775 0.198 0.552 to 3.615 0.008 1.283
Previous mental health diagnosis -2.892 1.064 -0.197 -4.993 to -0.790 0.007 1.252
Family history of mental illness -12.135 3.369 -0.242 -18.791 to -5.479 <0.001 1.072
Hot flashes 0.146 1.224 0.012 -2.273 to 2.565 0.906 2.541
Night sweats 1.656 1.164 0.140 -0.644 to 3.957 0.157 2.305
Sleep changes 2.579 1.612 0.116 -0.606 to 5.764 0.112 1.250
Vaginal dryness/discomfort -3.042 1.650 -0.131 -6.303 to 0.219 0.067 1.194
Weight gain/fat redistribution -3.677 1.694 -0.158 -7.023 to -0.330 0.032 1.263
Notes: B, unstandardized regression coefficient; SE, standard error; β, standardized regression coefficient; CI, confidence interval; VIF, variance inflation factor. Higher BDI scores indicate greater depressive symptom burden. For binary variables coded 1=Yes and 2=No, negative B values indicate higher scores in the Yes category. p<0.05 was considered statistically significant.
Table 3. Final hierarchical linear regression model for HAM-A total score.
Table 3. Final hierarchical linear regression model for HAM-A total score.
Variable B SE β 95% CI for B p-value VIF
Age -0.495 0.166 -0.238 -0.823 to -0.167 0.003 1.405
Age at menarche 0.470 0.245 0.134 -0.015 to 0.955 0.058 1.081
Age at final menstrual period 0.055 0.218 0.022 -0.377 to 0.486 0.803 1.781
Irregular cycles before menopause -2.786 1.665 -0.133 -6.076 to 0.505 0.096 1.406
Hot flashes 2.073 1.101 0.193 -0.102 to 4.248 0.062 2.316
Night sweats 0.238 1.074 0.022 -1.885 to 2.361 0.825 2.213
Sleep changes -1.022 1.632 -0.051 -4.248 to 2.204 0.532 1.446
Mood changes 1.420 1.829 0.066 -2.194 to 5.035 0.439 1.595
Mode of menopause 2.150 2.919 0.068 -3.619 to 7.920 0.463 1.873
Vaginal dryness/discomfort -2.439 1.608 -0.115 -5.618 to 0.739 0.131 1.279
Weight gain/fat redistribution -2.235 1.587 -0.106 -5.371 to 0.901 0.161 1.250
Notes: B, unstandardized regression coefficient; SE, standard error; β, standardized regression coefficient; CI, confidence interval; VIF, variance inflation factor. Higher HAM-A scores indicate greater anxiety severity. p < 0.05 was considered statistically significant.
Table 4. Final hierarchical linear regression model for B-IPF total score.
Table 4. Final hierarchical linear regression model for B-IPF total score.
Variable B SE β 95% CI for B p-value VIF
Age 0.103 0.408 0.021 -0.703 to 0.909 0.801 1.306
Educational level 4.031 2.152 0.157 -0.222 to 8.284 0.063 1.393
Financial status 4.242 1.965 0.184 0.358 to 8.126 0.033 1.435
Job responsibility position 14.718 4.817 0.264 5.198 to 24.238 0.003 1.473
Number of pregnancies 0.734 1.638 0.033 -2.504 to 3.973 0.655 1.066
Hot flashes 3.709 2.794 0.143 -1.812 to 9.231 0.186 2.300
Night sweats -2.485 2.759 -0.096 -7.939 to 2.968 0.369 2.250
Sleep changes -2.744 3.876 -0.056 -10.405 to 4.917 0.480 1.256
Vaginal dryness/discomfort -2.523 3.875 -0.050 -10.180 to 5.135 0.516 1.144
Notes: B, unstandardized regression coefficient; SE, standard error; β, standardized regression coefficient; CI, confidence interval; VIF, variance inflation factor; B-IPF, Brief Inventory of Psychosocial Functioning. Higher B-IPF scores indicate greater psychosocial dysfunction. p<0.05 was considered statistically significant.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.